Determination of CYP2D6 Phenotyping for Metoprolol using CYP2D6 Genotype-derived Activity Score: Results from a Prospective, Clinical Trial
Author/sThomas, C D; Monsely, S A; El Rouby, N; Kim, S; Lingineni, K; Langaee, T; Langaee, T; Gong, Y; Johnson, J A; Schmidit, S O; Fyre, R F; Cavallari, L H
Date:03/13/2019
Meeting Name:2019 Annual Meeting, American Society for Clinical Pharmacology and Therapeutics (ASCPT)
State:FL
City:Orlando